Finally, we investigated a potential role of the PRR in the development of NASH, a more severe stage of NAFLD, finding that PRR antagonism reduced fibrosis development in the MCD diet-induced NASH mouse model. This evidence concerns the gene ATP6AP2 and metabolic dysfunction-associated steatotic liver disease.